ALKS Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
480.1M
-3.2%
496.0M
+26.2%
392.9M
+2.2%
384.5M
-2.4%
394.2M
Cost of Revenue
94.2M
-4.0%
98.1M
+59.3%
61.6M
+33.3%
46.2M
-10.4%
51.6M
Gross Profit
385.9M
-3.0%
397.9M
+20.1%
331.3M
-2.1%
338.3M
-1.2%
342.6M
Operating Expenses
349.9M
-7.8%
379.5M
-0.0%
379.6M
+35.5%
280.2M
+10.5%
253.5M
R&D
121.1M
+7.3%
112.9M
+9.3%
103.3M
+11.1%
93.0M
+13.8%
81.7M
SG&A
208.5M
-4.2%
217.6M
-17.8%
264.6M
+41.3%
187.2M
+9.0%
171.8M
Operating Income
36.0M
+96.3%
18.4M
+138.0%
-48280000
-183.1%
58.1M
-34.8%
89.1M
EBITDA
135.6M
+80.7%
75.0M
+360.1%
-28851000
-146.6%
62.0M
-36.2%
97.2M
Net Income
16.3M
+3150.9%
501.0K
+100.8%
-66480000
-234.7%
49.3M
-40.4%
82.8M
EPS (Basic)
$0.10
$0.00
+100.0%
$-0.40
-233.3%
$0.30
-40.0%
$0.50
EPS (Diluted)
$0.09
$0.00
+100.0%
$-0.40
-237.9%
$0.29
-40.8%
$0.49
Shares (Diluted)
176.4M
+1.7%
173.5M
+4.4%
166.2M
-1.9%
169.4M
+0.5%
168.5M
Alkermes (ALKS) — Financials